CD45/CD14 Monoclonal Antibody, FITC/PE Conjugated
Referentie MBS7135381-5x0,1mL
Formaat : 5x0.1mL
Merk : MyBiosource
CD45/CD14 Antibody – Mouse Monoclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS7135381MBS7135381 is an antibody targeting CD45/CD14. Also known as CD45/CD14 Monoclonal Antibody, FITC/PE Conjugated. Reactive in Human. Host: Mouse. More details
Product Overview
Online Datasheet in PDFProduct Name
CD45/CD14, Monoclonal Antibody
Full Product Name
CD45/CD14 Monoclonal Antibody, FITC/PE Conjugated
Product Gene Name
anti-CD45/CD14 antibody
Clonality
Monoclonal
Isotype
IgG2a, IgG1
Host
Mouse
Species Reactivity
Human
Form/Format
Liquid; Phosphate-Buffered Solution, pH 7.4, Containing 0.09% Sodium Azide and 0.2% (w/v) BSA
Purity/Purification
Affinity Purified
Preparation and Storage
Upon receipt, store at -20 degree C or -80 degree C. Avoid repeated freeze.
Molecular Weight
147,254 Da
Chromosome Location
Chromosome: 1; NC_000001.10 (198608098..198726605). Location: 1q31-q32
OMIM
126200
Immunogen
Recombinant Protein
Immunogen Species
Human
Conjugate
Non-conjugated
Product Categories/Family for anti-CD45/CD14 antibody
Immunology
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-CD45/CD14 antibody
ELISA (EIA), Flow Cytometry (FC/FACS)
Other Notes
Small volumes of anti-CD45/CD14 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for CD45/CD14. It may not necessarily be applicable to this product.
NCBI Official Full Name
receptor-type tyrosine-protein phosphatase C isoform 1
NCBI Official Synonym Full Names
protein tyrosine phosphatase, receptor type, C
NCBI Official Symbol
PTPRC
NCBI Official Synonym Symbols
LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180
UniProt Protein Name
Receptor-type tyrosine-protein phosphatase C
UniProt Synonym Protein Names
Leukocyte common antigen; L-CA; T200
UniProt Gene Name
PTPRC
UniProt Synonym Gene Names
CD45; L-CA
UniProt Entry Name
PTPRC_HUMAN
NCBI Protein Information
receptor-type tyrosine-protein phosphatase C; CD45 antigen; T200 glycoprotein; T200 leukocyte common antigen; protein tyrosine phosphatase, receptor type, c polypeptide
NCBI Summary for CD45/CD14
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jun 2012]
Show more UniProt Comments for CD45/CD14
CD45: a receptor type protein tyrosine phosphatase protein. Contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains. The first PTPAse domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Specifically expressed in hematopoietic cells. An essential regulator of T- and B-cell antigen receptor signaling. Functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. Suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Four alternatively spliced isoforms have been described.
Protein type: Membrane protein, integral; Motility/polarity/chemotaxis; Receptor protein phosphatase, tyrosine; EC 3.1.3.48
Chromosomal Location of Human Ortholog: 1q31-q32
Cellular Component: focal adhesion; membrane; integral to plasma membrane; plasma membrane; lipid raft; external side of plasma membrane
Molecular Function: protein binding; transmembrane receptor protein tyrosine phosphatase activity; protein tyrosine phosphatase activity; protein kinase binding
Biological Process: B cell proliferation; axon guidance; substrate-bound cell migration, cell release from substrate; regulation of cell cycle; protein amino acid dephosphorylation; positive regulation of antigen receptor-mediated signaling pathway; T cell receptor signaling pathway; bone marrow development; B cell receptor signaling pathway; stem cell development; cell surface receptor linked signal transduction; dephosphorylation; release of sequestered calcium ion into cytosol; positive regulation of protein kinase activity; negative regulation of T cell mediated cytotoxicity; positive regulation of B cell proliferation; negative regulation of protein kinase activity; positive regulation of T cell proliferation; hemopoietic progenitor cell differentiation; negative regulation of cytokine and chemokine mediated signaling pathway; immunoglobulin biosynthetic process; defense response to virus; T cell differentiation
Disease: Hepatitis C Virus, Susceptibility To; Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative, B Cell-positive, Nk Cell-positive
Show more Protein type: Membrane protein, integral; Motility/polarity/chemotaxis; Receptor protein phosphatase, tyrosine; EC 3.1.3.48
Chromosomal Location of Human Ortholog: 1q31-q32
Cellular Component: focal adhesion; membrane; integral to plasma membrane; plasma membrane; lipid raft; external side of plasma membrane
Molecular Function: protein binding; transmembrane receptor protein tyrosine phosphatase activity; protein tyrosine phosphatase activity; protein kinase binding
Biological Process: B cell proliferation; axon guidance; substrate-bound cell migration, cell release from substrate; regulation of cell cycle; protein amino acid dephosphorylation; positive regulation of antigen receptor-mediated signaling pathway; T cell receptor signaling pathway; bone marrow development; B cell receptor signaling pathway; stem cell development; cell surface receptor linked signal transduction; dephosphorylation; release of sequestered calcium ion into cytosol; positive regulation of protein kinase activity; negative regulation of T cell mediated cytotoxicity; positive regulation of B cell proliferation; negative regulation of protein kinase activity; positive regulation of T cell proliferation; hemopoietic progenitor cell differentiation; negative regulation of cytokine and chemokine mediated signaling pathway; immunoglobulin biosynthetic process; defense response to virus; T cell differentiation
Disease: Hepatitis C Virus, Susceptibility To; Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative, B Cell-positive, Nk Cell-positive
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-CD45/CD14 antibody
| Reference Product | PubMed Publications |
|---|---|
| CD4 antibody | >2767 publications with CD45/CD14 and CD4 |
| CD28 antibody | >381 publications with CD45/CD14 and CD28 |
| CD2 antibody | >341 publications with CD45/CD14 and CD2 |
| LCK antibody | >202 publications with CD45/CD14 and LCK |
| ITGAL antibody | >191 publications with CD45/CD14 and ITGAL |
| CD22 antibody | >116 publications with CD45/CD14 and CD22 |
| CXCR4 antibody | >114 publications with CD45/CD14 and CXCR4 |
| FYN antibody | >76 publications with CD45/CD14 and FYN |
| LYN antibody | >43 publications with CD45/CD14 and LYN |
| ZAP70 antibody | >37 publications with CD45/CD14 and ZAP70 |
Pathways associated with anti-CD45/CD14 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| B Cell Receptor Signaling Pathway antibodies | B Cell Receptor Signaling Pathway Diagram |
| BCR Signaling Pathway antibodies | BCR Signaling Pathway Diagram |
| CXCR4-mediated Signaling Events Pathway antibodies | CXCR4-mediated Signaling Events Pathway Diagram |
| Cell Adhesion Molecules (CAMs) Pathway antibodies | Cell Adhesion Molecules (CAMs) Pathway Diagram |
| Cell Adhesion Molecules (CAMs) Pathway antibodies | Cell Adhesion Molecules (CAMs) Pathway Diagram |
| Developmental Biology Pathway antibodies | Developmental Biology Pathway Diagram |
| EPO Receptor Signaling Pathway antibodies | EPO Receptor Signaling Pathway Diagram |
| Fc Gamma R-mediated Phagocytosis Pathway antibodies | Fc Gamma R-mediated Phagocytosis Pathway Diagram |
Diseases associated with anti-CD45/CD14 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >1893 publications with CD45/CD14 and Neoplasms |
| Lymphoma Antibodies | >844 publications with CD45/CD14 and Lymphoma |
| Inflammation Antibodies | >578 publications with CD45/CD14 and Inflammation |
| Necrosis Antibodies | >437 publications with CD45/CD14 and Necrosis |
| Brain Diseases Antibodies | >278 publications with CD45/CD14 and Brain Diseases |
| Lung Diseases Antibodies | >235 publications with CD45/CD14 and Lung Diseases |
| Multiple Myeloma Antibodies | >178 publications with CD45/CD14 and Multiple Myeloma |
| Neoplasms, Experimental Antibodies | >153 publications with CD45/CD14 and Neoplasms, Experimental |
| Skin Neoplasms Antibodies | >140 publications with CD45/CD14 and Skin Neoplasms |
| Arthritis, Rheumatoid Antibodies | >139 publications with CD45/CD14 and Arthritis, Rheumatoid |
Organs/Tissues associated with anti-CD45/CD14 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >6424 publications with CD45/CD14 and Blood |
| Bone Antibodies | >1702 publications with CD45/CD14 and Bone |
| Bone Marrow Antibodies | >1593 publications with CD45/CD14 and Bone Marrow |
| Vascular Antibodies | >682 publications with CD45/CD14 and Vascular |
| Lymph Node Antibodies | >602 publications with CD45/CD14 and Lymph Node |
| Lymph Antibodies | >599 publications with CD45/CD14 and Lymph |
| Spleen Antibodies | >595 publications with CD45/CD14 and Spleen |
| Liver Antibodies | >481 publications with CD45/CD14 and Liver |
| Thymus Antibodies | >474 publications with CD45/CD14 and Thymus |
| Skin Antibodies | >442 publications with CD45/CD14 and Skin |


